Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling
Cancer Communications · 2023-12 · 43 (12) · 1354-1372
DOI: 10.1002/cac2.12482 ↗At a glance
Journal article in Cancer Communications, published online on 2023-09-05. Written by Dandan Qi and 12 co-authors. Institution: Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. Cited 44 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Key R&D Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, National Basic Research Program of China.
Abstract (original language)
Background
Hepatic inflammation is the major risk factor of hepatocellular carcinoma (HCC). However, the underlying mechanism by which hepatic inflammation progresses to HCC is poorly understood. This study was designed to investigate the role of ETS translocation variant 4 (ETV4) in linking hepatic inflammation to HCC.
Methods
Quantitative real‐time PCR and immunoblotting were used to detect the expression of ETV4 in HCC tissues and cell lines. RNA sequencing and luciferase reporter assays were performed to identify the target genes of ETV4. Hepatocyte‐specific ETV4 ‐knockout ( ETV4 fl/fl, alb‐cre ) and transgenic ( ETV4 Hep‐TG ) mice and diethylnitrosamine‐carbon tetrachloride (DEN‐CCL 4 ) treatment experiments were applied to investigate the function of ETV4 in vivo . The Cancer Genome Atlas (TCGA) database mining and pathological analysis were carried out to determine the correlation of ETV4 with tumor necrosis factor‐alpha (TNF‐α) and mitogen‐activated protein kinase 11 (MAPK11).
Results
We revealed that ETV4 was highly expressed in HCC. High levels of ETV4 predicted a poor survival rate of HCC patients. Then we identified ETV4 as a transcription activator of TNF‐α and MAPK11. ETV4 was positively correlated with TNF‐α and MAPK11 in HCC patients. As expected, an increase in hepatic TNF‐α secretion and macrophage accumulation were observed in the livers of ETV4 Hep‐TG mice. The protein levels of TNF‐α, MAPK11, and CD68 were significantly higher in the livers of ETV4 Hep‐TG mice compared with wild type mice but lower in ETV4 fl/fl, alb‐cre mice compared with ETV4 fl/fl mice as treated with DEN‐CCL 4 , indicating that ETV4 functioned as a driver of TNF‐α/MAPK11 expression and macrophage accumulation during hepatic inflammation. Hepatocyte‐specific knockout of ETV4 significantly prevented development of DEN‐CCL 4 ‐induced HCC, while transgenic expression of ETV4 promoted growth of HCC.
Conclusions
ETV4 promoted hepatic inflammation and HCC by activating transcription of TNF‐α and MAPK11. Both the ETV4/TNF‐α and ETV4/MAPK11 axes represented two potential therapeutic targets for highly associated hepatic inflammation and HCC. ETV4+TNF‐α were potential prognostic markers for HCC patients.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, P. R. China.
- Savaid Medical School, University of Chinese Academy of Sciences, Beijing, P. R. China.
- The Fifth Medical Center of Chinese People's Liberation Army General Hospital, Beijing, P. R. China.
- School of Life Sciences, University of Science and Technology of China, Hefei, Anhui, P. R. China.
ORCID profiles: Xin Ye
Funding
- National Key R&D Program of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- National Basic Research Program of China
Cite
APA
Qi, D., Lu, M., Xu, P., Yao, X., Chen, Y., Gan, L., Li, Y., Cui, Y., Tong, X., Liu, S., Zhao, J., Liu, N., & Ye, X. (2023). Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling. Cancer Communications, 43(12), 1354-1372. https://doi.org/10.1002/cac2.12482
Vancouver
Qi D, Lu M, Xu P, Yao X, Chen Y, Gan L, et al. Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling. Cancer Communications. 2023;43(12):1354-1372. doi:10.1002/cac2.12482
BibTeX
@article{Qi2023,
author = {Qi, Dandan and Lu, Min and Xu, Pengfei and Yao, Xinli and Chen, Yongchen and Gan, Lipeng and Li, Yong and Cui, Yahua and Tong, Xiaomei and Liu, Shuhong and Zhao, Jingmin and Liu, Ningning and Ye, Xin},
title = {Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF‐α signaling},
journal = {Cancer Communications},
year = {2023},
volume = {43},
number = {12},
pages = {1354--1372},
doi = {10.1002/cac2.12482}
}
EUVIMED